En español
NIDA

Search

Menu

Scientific Review Group/Committee Structure

Revised February 2013

Office of Extramural Affairs Grant and Contract Review Committees

Code Committee Name or Description Scientific Review Officer Research Areas
NIDA/K Training and Career Development Eliane Lazar-Wesley, Ph.D.
301-451-4530
NIDA's remaining Institute-based standing review committee that reviews grant applications for career development and institutional training in research relevant to NIDA; will transition to CSR October, 2012.
ZDA1-___- Special Emphasis
Panels (SEP)
Various NIDA SROs A NIDA Special Emphasis Panel (SEP) is recruited by the SRO for a special review, often a unique RFA or a Program Announcement (PA), or for contract proposals. Some recurring SEP reviewed at NIDA are listed below.
ZDA1-EXL-T Special Emphasis Panel (SEP) for NIDA Centers Eliane Lazar-Wesley, Ph.D.
301-451-4530
Review complex multidisciplinary, multi-component applications with administrative and scientific cores and projects related to an integrating theme.
ZDA1-___- Special Emphasis Panel (SEP) for assorted FOAs Various NIDA SROs Review applications involving multi-site clinical trials, time-sensitive applications, R25 mechanisms, Avant Garde.
ZDA1-SXC-A Special Emphasis Panel(SEP) for Avant-Garde
RFA-DA-12-010
Scott Chen, Ph.D.
301-443-9511

Review grant applications designed by individual scientists of exceptional creativity who propose approaches at the forefront of drug abuse and HIV/AIDS research.

ZDA1-MXL-A Special Emphasis Panel (SEP) for
Conference Grants
PA-08-149
Minna Liang, Ph.D.
301-435-1432
Review grant applications for high quality conferences/ scientific meetings relevant to NIDA's scientific and public health issues.
ZDA1-GXM-A Special Emphasis
Panel (SEP) for
I/START
PAR-06-311
Gerald McLaughlin, Ph.D.
301-402-6626
Review grant applications to facilitate the entry of beginning investigators with brain imaging research relevant to drug abuse.
ZDA1-SXC-A Special Emphasis
Panel (SEP) for
CEBRA
PAR-06-209
Scott Chen, Ph.D.
301-443-9511
Review grant applications to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them, and to support high-risk, potentially high-impact that is underrepresented or not included in NIDA's current portfolio.

*The standing review committees that reviewed the R mechanism, [NIDA/E (Treatment), NIDA/F (Health Services), and NIDA/L (Medication Development)], were dissolved in 2009, and most applications that would have been reviewed in these committees are now being reviewed in CSR.

Click here for rosters of review groups that are managed by the Center for Scientific Review or other Institutes.

General committee information contact:

Ms. Camilla L. Holland,
NIDA Committee Management Officer
(301)435-1384.

For specific committee information contact the Scientific Review Officer listed above.

Office Address:

Office of Extramural Affairs
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Boulevard
Room 4230, MSC 9550
Bethesda, Maryland 20892-9550

Grants and Contracts Frequently Asked Questions (FAQs)

This page was last updated February 2013

    Featured Publication

    Featured Publication

    Drugs, Brains, and Behavior - The Science of Addiction

    As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.